85 results
8-K/A
EX-99.4
COCP
Cocrystal Pharma Inc
15 Sep 11
Financial Statements and Exhibits
12:00am
. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based
CORRESP
COCP
Cocrystal Pharma Inc
13 Feb 13
Correspondence with SEC
12:00am
, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy
8-K/A
EX-99.3
COCP
Cocrystal Pharma Inc
15 Sep 11
Financial Statements and Exhibits
12:00am
) and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express
8-K/A
EX-99.1
lonws0wjchegh
20 Mar 14
Index to Financial Statements
12:00am
8-K
EX-10.2
1ru ns0xyvbzyzn9
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
CORRESP
34c7uv
29 Jul 10
Correspondence with SEC
12:00am
8-K/A
EX-99.2
jf3xevhg07f7cmce8
15 Sep 11
Financial Statements and Exhibits
12:00am
8-K/A
9xx3 aq0wja
9 Feb 15
Financial Statements and Exhibits
12:00am
S-8
EX-10.1
plvfos9azm
11 May 18
Registration of securities for employees
4:16pm
8-K
EX-10.1
4y5ucod
3 Nov 11
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
EX-10.6
uacftrw
1 Mar 11
Departure of Directors or Certain Officers
12:00am